The objectives of this Certificate of Advanced Studies (CAS) program are to increase managerial competences and to raise competitive advantage in Life Sciences, particularly in Medtech, Biotech and Pharma Ventures.
It is aimed at professionals in Medtech, Biotech, Pharma domains.
SPECIAL NOTICE RE: COVID-19
The CAS program is fully functional even though university campuses are closed across Switzerland. We have been proactive in shifting our courses to a digital format and have shifted all our current classes to remote live sessions for the duration of the coronavirus interruption.
We are continuing to accept and process applications in our normal, timely manner.
The CAS team is fully operational and available to answer any questions you may have, and wishes everyone the best of health.
If you want to undertake the CAS, you can start while the program is underway, completing the remaining modules the following year.
INTELLECTUAL PROPERTY MANAGEMENT IN LIFE SCIENCES
March 31-April 2, 2020
International intellectual property protection issues and strategies are highly important in domain such as medical devices, diagnostics, pharmaceuticals, biotechnology and generic. Strategic issues of IP and how patent, trade mark, etc. are created, managed and enforced will be addressed.
CLINICAL TRIAL MANAGEMENT & REGULATORY AFFAIRS
May 5-7 2020
Getting the authorizations and approvals for new medicines and devices is critical. The module will address how to manage and carry out clinical trials, while respecting the legislative framework. It covers good practices management and the regulations applying to medical devices & therapeutics.
CURRENT GOOD MANUFACTURING PRACTICE (cGMP)
May 26-28, 2020
Manufacturing facilities occupy a growing share of an enterprise’s strategic horizon. Planning, design, construction, qualification, validation and operation are key steps to deliver a production facility. Quality systems, GMP and their impact on Medtech and Biotech new process validation will be addressed.
June 16-18, 2020
The development of new devices and medicines is a long process. A thorough planning of different steps/ milestones of the project is key for reaching success. You will learn how to give project solid foundations, with due considerations for stakeholders, precise objectives and key success factors.
STRATEGIC ALLIANCES, PARTNERSHIP & OUTSOURCING
Jan 19-21, 2021
Enterprises in life sciences need considerable amounts of resources. Alliances, partnerships or outsourcing are often required for success. This module provides a framework to select partners; to identify the appropriate form of partnership (joint-venture, alliance or outsourcing) and to implement it.
MANAGING DATA FOR VALUE IN LIFE SCIENCES
Feb 9-11, 2021
Understanding the challenges and opportunities in data and the strategies around data are highly important in domain such as medical devices, diagnostics, pharmaceuticals, biotechnology and generic pharma. Strategic issues of how to approach opportunities with data at the heart and how projects are created, managed and delivered with value in different systems will be addressed.
MARKETING IN LIFE SCIENCES
April 13-15, 2021
The key challenge in life sciences sector is to grow the business in increasingly competitive & global markets. With this module you will grasp the global market environment (customers, competitors, channels); improve your command of concepts & methods to design/ implement marketing strategies.
* Dates of modules may be subject to change
These modules address key managerial issues and are led by top European Professors and Executives from Industry. They are be case study oriented.
Program participation is flexible. Participants can choose to follow the whole program or select the modules they have an interest in.
|Per module||2 modules||3 modules||4 modules|
|CHF 2’450||CHF 4’400||CHF 6’050||CHF 7’400|
|5 modules||6 modules||7 modules|
|CHF 8’450||CHF 9’200||CHF 9’650|
Although it is possible to take the CAS over two years, the progressive pricing as stated above is only applicable if the full amount is paid in the first year, by June 30th. (Example: taking two modules year 1 and three modules year two means a payment of CHF 8’450 if paid in the first year, versus CHF 4’400 year 1 and CHF 6’050 year 2).
CAS in Management of BioTech, MedTech and Pharma ventures allowed me to deepen my knowledge of regulated industries and gain multiple valuable industry connections. It is an excellent program and I recommend it anyone who wants to gain valuable insights in Bio-pharmaceutical and Medical Device Industry, and benefit from a remarkable selection of speakers.
Aston Life Sciences
Being an engineer in a medical device company is not only technically challenging but it requires knowledge in the fields of Quality and Regulatory, IP, Project Management and Marketing/ Sales, exactly the 5 modules I chose. Many real-life examples and experiences were shared and this gave the lectures the “non-academic” character that suited better the expectations of the majority of the participants.
I would definitely recommend it to any professional that would like either to get a good idea of the challenges in these very important fields or even refresh any existing knowledge.
Development & Design Assurance Engineer
ALEVA Neurotherapeutics SA
The CAS course helped me to extend my MedTech/Biotech knowhow to unknown areas such as Clinicals Trials and Strategic Alliances. Complemented by relevant cases studies, this course will be for sure an asset in my career going forward.
Director Product Delivery,